Caspofungin acetate 70 MG Injection [Cancidas]

Known as: CASPOFUNGIN ACETATE 7 mg in 1 mL INTRAVENOUS INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [CANCIDAS], Cancidas 70 MG (equivalent to caspofungin 75.6 MG) Injection, Cancidas 70 MG Injection 
 
National Institutes of Health

Related topics

Related topics

8 relations
Acetic AcidCancidasCaspofunginCaspofungin acetate
(More)

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2014
Review
2014
Discovery and development of first in class antifungal caspofungin (CANCIDAS®)--a case study.
Covering: 1985 to 2001.This paper describes a fifteen year journey from concept to clinical discovery and development of the… (More)
Is this relevant?
2013
2013
Caspofungin (Cancidas®) in the treatment for Candida albicans meningitis
 
Is this relevant?
2012
2012
From lab to patient: Development of API and formulation manufacturing processes for Cancidas®
 
Is this relevant?
Review
2006
Review
2006
[Caspofungin: mode of action and therapeutic applications].
SUBJECT Since the last two decades, the incidence of invasive fungal infections has drastically increased. It becomes urgent to… (More)
Is this relevant?
2002
2002
INTRAVENOUS INFUSION ( not for IV Bolus Injection ) CANCIDAS ® ( caspofungin acetate ) FOR INJECTION DESCRIPTION
  • 2002
CANCIDAS is a sterile, lyophilized product for intravenous (IV) infusion that contains a semisynthetic lipopeptide (echinocandin… (More)
  • table 1
  • table 2
  • table 7
  • table 8
  • table 9
Is this relevant?